Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $13.59 USD
Change Today -0.32 / -2.30%
Volume 408.7K
As of 2:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Rick E. Winningham

AgeTotal Calculated CompensationThis person is connected to 84 board members in 5 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Rick E. Winningham has been the Chairman and Chief Executive Officer at Theravance Biopharma, Inc. since its spin-off from Theravance, Inc. in June 2014. Mr. Winningham served as the Chief Executive Officer of Theravance Inc. from October 2001 to August 15, 2014. He served as the President of Theravance Inc. since October 2001. From 1997 to 2001, he served as the President of Bristol-Myers Squibb Oncology /Immunology /Oncology Therapeutics Network (OTN) and as the ...

Read Full Background

Corporate Headquarters*

951 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-238-9600
Fax: --

Board Members Memberships*

Lead Independent Director and Member of Nominating & Corporate Governance Committee
Chairman, Chief Executive Officer and Member of Science & Technology Committee


Texas Christian University
Southern Illinois University, Carbondale Campus

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,366,250

Stock Options*

Restricted Stock Awards$6,597,645
All Other Compensation$500
Exercisable Options175,372
Unexercisable Options400,000
Total Number of Options575,372

Total Compensation*

Total Annual Cash Compensation$1,366,750
Total Short Term Compensation$1,366,250
Other Long Term Compensation$6,598,145
Total Calculated Compensation$14,899,123
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THRX:US $13.59 USD -0.32


Clive A. Meanwell M.D., Ph.D.Chief Executive Officer and Director
The Medicines Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAVANCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at